← All trials
NCT04238416
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2019
- Primary completion
- Sep 30, 2022
- Completion date
- Sep 30, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 68
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Postgraduate Institute of Medical Education and ResearchLead sponsor
- Postgraduate Institute of Medical Education and ResearchOverall official - principal investigator
- Postgraduate Institute of Medical Education and ResearchReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.